OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
506008$1.0354

Great Wall Science and Technology Innovation Board 2-Year Regular Open Mixed Securities Investment Fund

Closed End FundsVerified

The fund has a market price of $1.035 per share and a market capitalization of $77.6 million, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for the fund, as it is a closed-end fund and does not report traditional financial performance indicators such as net income or return on equity. The fund's performance is typically evaluated based on its net asset value (NAV) and total return to investors, which are not provided in the current dataset. The fund's exposure is concentrated in the science and technology innovation board, as disclosed in its investment strategy. However, no further breakdown of geographic or segment revenue concentration is available in the input data. The fund's growth trajectory is not quantifiable in the current dataset, as no revenue history or outlook for the current or next fiscal year is provided. The fund's performance is likely influenced by the broader market conditions and the performance of the innovation board, but no specific numeric deltas or directional indicators are available. The fund is assessed as having low dilution risk, with no near-term pressure from additional share issuance or other dilutive events. The absence of balance-sheet inputs and lack of going-concern language in source documents prevent a full liquidity risk assessment. No recent events, such as filings or transcripts, are provided in the input data to inform the fund's current operational or strategic developments.

30-day price · 506008+0.20 (+22.5%)
Low$0.89High$1.13Close$1.10As of15 May, 00:00 UTC
Profile
CompanyGreat Wall Science and Technology Innovation Board 2-Year Regular Open Mixed Securities Investment Fund
Ticker506008.SS
SectorFinancials
BusinessCollective Investments
Industry groupCollective Investments
IndustryClosed End Funds
AI analysis

Business. Great Wall Science and Technology Innovation Board 2-Year Regular Open Mixed Securities Investment Fund is a closed-end fund that invests in a mixed portfolio of securities, primarily focused on the science and technology innovation board, and generates returns through capital appreciation and income from its investments.

Classification. The company is classified under the Financials economic sector, Collective Investments business sector, and Closed End Funds industry, with a confidence level of 0.92 based on verified market data.

The fund has a market price of $1.035 per share and a market capitalization of $77.6 million, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for the fund, as it is a closed-end fund and does not report traditional financial performance indicators such as net income or return on equity. The fund's performance is typically evaluated based on its net asset value (NAV) and total return to investors, which are not provided in the current dataset. The fund's exposure is concentrated in the science and technology innovation board, as disclosed in its investment strategy. However, no further breakdown of geographic or segment revenue concentration is available in the input data. The fund's growth trajectory is not quantifiable in the current dataset, as no revenue history or outlook for the current or next fiscal year is provided. The fund's performance is likely influenced by the broader market conditions and the performance of the innovation board, but no specific numeric deltas or directional indicators are available. The fund is assessed as having low dilution risk, with no near-term pressure from additional share issuance or other dilutive events. The absence of balance-sheet inputs and lack of going-concern language in source documents prevent a full liquidity risk assessment. No recent events, such as filings or transcripts, are provided in the input data to inform the fund's current operational or strategic developments.
Key takeaways
  • The fund has a market price of $1.035 and a market capitalization of $77.6 million.
  • There is no difference between basic and diluted shares outstanding, indicating no immediate dilution risk.
  • Liquidity risk could not be assessed due to missing balance-sheet inputs and lack of going-concern language.
  • The fund's performance is likely tied to the science and technology innovation board, but no detailed segment or geographic exposure is available.
  • No recent events or outlook data are provided to assess the fund's growth trajectory or strategic direction.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$1.03
Market cap$77.6M
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Closed End Funds · cohort 11 companies
Metric506008Activity
Op margin55.6% medp25 35.9% · p75 83.7%
Net margin54.5% medp25 -2.5% · p75 86.3%
Gross margin67.0% medp25 47.0% · p75 89.7%
CapEx / revenue-3.8% medp25 -7.7% · p75 -0.6%
Debt / equity7.0% medp25 0.0% · p75 77.9%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 02:05 UTC#4a11180d
Market quoteclose USD 1.03 · shares 0.07B diluted
no public URL
2026-05-05 02:05 UTC#9ebe6c0c
Source: analysis-pipeline (hybrid)Generated: 2026-05-05 02:06 UTCJob: 35149448